NSF International expands health sciences div with 3 key appointments

NSF International, a global independent public health organisation that writes standards, and tests and certifies products for the health sciences, water, food, and consumer goods industries, has welcomed three leading pharmaceutical and biotechnology experts to its Health Sciences Division.

Janeen Skutnik	Stephen Engels	Peter Langlais

Janeen Skutnik joins as a Partner with the Boston-based US team of NSF-DBA, an NSF International company with over 25 years of experience delivering training, auditing and consulting to the pharma and medical device industries.

Stephen Engels joins NSF-DBA as a Principal Consultant, overseeing operations in Switzerland, Italy, Germany and Austria while Peter Langlais joins as Business Development Director for the entire NSF International Health Sciences Division.

The NSF International Health Sciences Division offers training and education, consulting, auditing, GMP and GLP testing, certification, R&D and regulatory guidance to the pharma, biotech, medical device, over-the-counter and dietary supplement industries throughout the product lifecycle.

NSF-DBA US as regulatory agencies worldwide have increased their focus on pharma quality and supply chain practices in the face of globalisation, there is an even greater emphasis on quality systems and training. In her new role as a Partner at NSF-DBA US, Skutnik will address these and other issues by providing high quality training and consulting to leading pharma, biotech, medical device and dietary supplement companies. Her expertise in the area of excipients and OTC products will assist NSF-DBA customers in complying with new and emerging quality regulations and global supply chain best practices.

Working closely with Skutnik, Engels will head quality management systems consulting, auditing and training activities. Engels’s career in pharma quality and compliance spans more than 25 years. He is a quality management systems expert with experience in supplier management, auditor development and regulatory compliance, including leading quality assurance roles at Merck Serono in Switzerland and Italy where he developed and implemented a global auditor qualification and training programme as Head of its Quality Programmes and Systems Development.

Langlais joins as Business Development Director for the NSF Health Sciences Division, which includes NSF-DBA, NSF Pharmalytica, NSF Becker, NSF Reference Standards and NSF’s Dietary Supplements group. Langlais has more than 24 years of sales and marketing experience with suppliers to major pharma and biotech firms. In his new role, he will help expand NSF’s services in biotech, pharma, reference standards, medical device and dietary supplement markets.

“Engels and Skutnik’s innovative approach to quality assurance in the pharma and biotech sectors has made them both a widely sought resource for government officials and global pharma companies, and Langlais’ experience working with global pharma and biotech companies will help NSF Health Sciences expand our services to new areas,” said Lori Bestervelt, Chief Science Officer and Senior Vice President, NSF International.

“All three are valuable additions to the NSF Health Sciences team. Together, their combined 70 years of experience in pharma quality systems and global supply chain best practices will help NSF assist companies in meet their quality and compliance goals.”

Based in Ann Arbor, Michigan, US, and established in 1944, NSF is committed to protecting human health and safety worldwide and operates in more than 150 countries. NSF is a World Health Organization Collaborating Centre for Food and Water Safety and Indoor Environment.

EP News Bureau – Mumbai